Cargando…
Comparison of planning techniques when air/fluid is present using the strut‐adjusted volume implant (SAVI) for HDR‐based accelerated partial breast irradiation
The presence of air/fluid surrounding implantable devices used for partial breast irradiation may significantly impact dose coverage to at‐risk tissue. Of the 67 total patients retrospectively evaluated for this study, 32 (48%) had greater than 1 cc volume of air/fluid extending outside of the strut...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714640/ https://www.ncbi.nlm.nih.gov/pubmed/24257287 http://dx.doi.org/10.1120/jacmp.v14i6.4442 |
Sumario: | The presence of air/fluid surrounding implantable devices used for partial breast irradiation may significantly impact dose coverage to at‐risk tissue. Of the 67 total patients retrospectively evaluated for this study, 32 (48%) had greater than 1 cc volume of air/fluid extending outside of the strut‐adjusted volume implant (SAVI) device surface and were selected for comparison of planning approaches. The planning approaches utilized two different definitions of PTV_EVAL. One definition of a PTV_EVAL [Formula: see text] was based on expanding 1 cm beyond the SAVI device only while accounting for the air/fluid using the NSABP Protocol B‐39/RTOG Protocol 0413. The second PTV_EVAL definition [Formula: see text] was based on expanding 1 cm beyond the cavity (SAVI device plus air/fluid volume). The results indicate use of the B‐39 formalism to account for air/fluid displacing the PTV_EVAL may overestimate the dose coverage to the at‐risk tissue, especially for large contiguous volumes of air/fluid. Using the SAVI device to optimize dose covering the [Formula: see text] volume surrounding the cavity improves dosimetric coverage to at‐risk tissue by 11.3% and 8.7% for V100 and V90, respectively, while the average V150 and V200 indices for [Formula: see text] increased by 9.1 cc and 5.0 cc, respectively, and the average maximum rib and skin doses increased by 11. 1% and 6.1%, respectively. The maximum skin dose, rib dose, V150, and V200 all met the planning objectives despite any increase in these parameters. PACS number: 87.55.kh |
---|